Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 97872572 | 9787257 | 2 | F | 20110301 | 20151204 | 20131230 | 20160905 | EXP | GB-ROCHE-1326372 | ROCHE | 70.00 | YR | M | Y | 0.00000 | 20160905 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 97872572 | 9787257 | 1 | PS | CAPECITABINE. | CAPECITABINE | 1 | Oral | ON DAYS 1 TO 21 | U | 20896 | TABLET | BID | |||||||
| 97872572 | 9787257 | 2 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | OVER 30 MINUTES DAY 1, 8 AND 15 | U | 0 | |||||||||
| 97872572 | 9787257 | 3 | C | TAMSULOSIN | TAMSULOSIN | 1 | 0 | ||||||||||||
| 97872572 | 9787257 | 4 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | ||||||||||||
| 97872572 | 9787257 | 5 | C | MORPHINE SULFATE. | MORPHINE SULFATE | 1 | 0 | ||||||||||||
| 97872572 | 9787257 | 6 | C | BENDROFLUMETHIAZID | 2 | 0 | |||||||||||||
| 97872572 | 9787257 | 7 | C | DILTIAZEM. | DILTIAZEM | 1 | 0 | ||||||||||||
| 97872572 | 9787257 | 8 | C | RAMIPRIL. | RAMIPRIL | 1 | 0 | ||||||||||||
| 97872572 | 9787257 | 9 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | 0 | ||||||||||||
| 97872572 | 9787257 | 10 | C | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
| 97872572 | 9787257 | 11 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 97872572 | 9787257 | 1 | Pancreatic carcinoma metastatic |
| 97872572 | 9787257 | 2 | Pancreatic carcinoma metastatic |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 97872572 | 9787257 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 97872572 | 9787257 | Obstruction gastric | |
| 97872572 | 9787257 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |